Bristol-Myers Squibb Company (BMY) · page 27 of 197
This is a classic 'preempt_rebuttal' slide used by activist investors to undermine management's deal rationale.
Activist deck · preempt_rebuttal · preempt_rebuttal · dense density
Slide locked Sign in to view
Slide schematic 5/7
callout 1/2 list 1/1 metric 0/1 paragraph 1/1 source-note 1/1 title 1/1
2 without position callout 1 · metric 1
calloutmetric · primary
Components 7
primary callout bullet primary paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1